Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL

Transfusion and Apheresis Science

Volumn 36, Issue 2, 2007, Pages 149-158

  Gašová, Zdenka ^a   Spíšek, Radek ^b   Doležalová, Ludmila ^a   Marinov, Iuri ^a   Vítek, Antonín ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Allogeneic transplantation; Chronic GVHD; CTCL Mycosis fungoides; ECP; Extracorporeal photochemotherapy; Hematopoietic stem cell transplantation; Photopheresis

Indexed keywords

METHOXSALEN;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; CELL FUNCTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COUGHING; CUTANEOUS T CELL LYMPHOMA; DENDRITIC CELL; FEMALE; FEVER; HUMAN; HYPOCALCEMIA; INFECTIOUS COMPLICATION; JOINT MOBILITY; KIDNEY FUNCTION; LIVER FUNCTION; LYMPHOCYTE COUNT; MALE; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AUTOMATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PHOTOPHERESIS; TREATMENT OUTCOME;

EID: 34248208577     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.01.002     Document Type: Article

References (25)

1. Ratanatharathorn V., Ayash L., Lazarus H.M., Fu J., and Uberti J.P. Chronic graft versus host disease: clinical manifestation and therapy. Bone Marrow Transpl 28 (2001) 121-129
2. Marcellus DC, Vogelsang GB. Chronic graft-versus host disease. In: Ball D, Lister J, Law P, editors. Hematopoietic stem cell therapy. Churchill Livingstone; 2000. p. 614-24 [chapter 54].
3. Vogelsang G.B., Wolff D., Altomonte V., Farmer E., Morrison W.L., Corio R., et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transpl 17 (1996) 1061-1067
4. Sullivan K.M., Witherspoon R.P., Storb R., et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72 2 (1988) 555-561
5. Lazarus H.M., Vogelsang G.B., and Rowe J.M. Prevention and treatment of acute GVHD: the old and the new. A report from the Eastern Cooperative Oncology group (ECOG). Bone Marrow Transpl 19 (1997) 577-600
6. Ferrara J.L. Cytokine dysregulation as a mechanism of graft-versus-host disease. Curr Opin Immunol 5 (1993) 794-799
7. Child F.J., Ratnavel R., Watkins P., et al. ECP in the treatment of chronic Graft versus Host Disease. Bone Marrow Transpl 23 (1999) 881-887
8. Bladon J., and Taylor P.C. ECP induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and GVHD patients. Brit J Haematol 107 (1999) 707-711
9. Van Iperen P., and Beijersbergen van Henegouwen G.M.J. Clinical and mechanistic aspects of photopheresis. New trends in photobiology. J Photoch Photobiol B 39 (1997) 99-109
10. Sniecinski I. Extracorporeal photochemotherapy: a scientific overview. Transfus Sci 15 (1994) 429-437
11. Schooneman F., and Claise C. Treatment of GVHD by Photopheresis?. Transfus Sci (1996) 527-536
12. Edelson R.L. Transimmunization: the science catches up to the clinical success. Transfus Apher Sci 26 (2002) 178-180
13. Klosner G., Trautinger F., Knobler R., and Neuner P. Treatment of peripheral blood mononuclear cells with 8-MOP Plus UV-A induces a shift in cytokine expression from a Th 1 to Th 2 response. J Invest Dermatol 116 (2001) 459-462
14. Edelson R., Berger C., Gasparro F., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. New Engl J Med 316 (1987) 297-303
15. Gaziev D., Galimberti M., Lucarelli G., et al. Chronic GVHD: is there an alternative to the conventional treatment?. Bone Marrow Transpl 25 (2000) 689-696
16. Kapoor N., Pellegrini A.E., Copelan E.A., Cunningham I., Avalos B.R., Klein J.L., et al. Psoralen Plus Ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients. Semin Hematol 29 (1992) 108-112
17. Owsianowski M., Gollnick H., Siegert W., et al. Successful treatment of chronic GVHD with extracorporeal photopheresis. Bone Marrow Transpl 14 (1994) 845-848
18. Owsianowski M., Garbe C., Remaker J., Orfanos C.E., and Gollnick H. Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow up and clinical outcome in 31 skin diseases. Hautartzt 47 (1996) 114-123
19. Andreu G., Leon A., Heshmati F., et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci 15 (1994) 443-454
20. Salvaneschi L., Perroti C., and Torretta L. Adverse effects associated with extracorporeal photochemotherapy. Transfusion 40 (2000) 121-1
21. Foss F.M. New insights in the mechanism of action of extracorporeal photochemotherapy. Transfusion 46 (2006) 6-8
22. Foss F.M., Gorgun G., and Miller K.B. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transpl 29 (2002) 719-725
23. Spíšek R., Gašová Z., and Bartůňková J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft versus host disease. Transfusion 46 (2006) 55-65
24. Rossetti F., Dal'Amico R., and Crovetti G. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transpl 18 (1996) 175-178
25. Girardi M., Schechner J., Glusac E., Berger C., and Edelson R. Transimmunization and the evolution of extracorporeal photochemotherapy. Transfus Apher Sci 26 (2002) 181-190